Prolonged deficiency can result in megaloblastic anaemia and, critically, irreversible neurological damage if left untreated
Counterfeit drugs are distinct from compounded versions, which pharmacies produce under specific regulatory allowances during drug shortages
Dosing in the Phase 3 Diabetes Trial (TRANSCEND-T2D-1) A1C reduction: -1.7% to -2.0% across doses (from baseline 7-9.5%) Weight loss at 12 mg: 16.8% (-36.6 lbs) at 40 weeks Discontinuation due to adverse events was relatively low across all doses, similar to the patterns seen in TRIUMPH-4 The diabetes population typically loses less weight on GLP-1 drugs than the obesity-only population, which is consistent with what was observed: ~17% weight loss in T2D vs
The generic version "is expected to provide the same therapeutic effect at a lower cost for eligible patients," said Shoppers
Furthermore, EGCG exhibits iron chelation capabilities, scavenges free radicals, and exerts significant antioxidant effects, as evidenced by pertinent studies (31)
It is highly suitable for extended experimental protocols and dose-response studies